Valuation dashboard for Nano-X Imaging Ltd. (NNOX) with P/E N/A, P/B 0.46, EV/EBITDA -0.43 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging.
Analysis Summary
Trailing-twelve-month margins: gross margin -85.7%, operating margin -422.9%, net margin -5.2%.
At the current price of $0.75, NNOX has negative trailing earnings (P/E not meaningful) and an ROE of -51.88%. Market capitalisation stands at $52M.
Balance sheet quality for NNOX: current ratio of 4.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.46 |
| EV / EBITDA | -0.43 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-5.31 |
| vs Current Price | -805.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | $52M | 0.46 | -51.9% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $0.75 |
| Market Cap | $52M |
| Exchange | NASDAQ |
| Country | IL |
Profitability
| Return on Equity | -51.88% |
| Return on Invested Capital | -44.33% |
| Return on Assets | -52.17% |
| Gross Margin | -85.67% |
| Operating Margin | -422.95% |
| Net Margin | -523.83% |
Related companies: CATX · HCAT · HSDT · INGN · MXCT · OM · PROF
Explore sector: Healthcare · Medical - Devices
More sections of NNOX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks